Hesong Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hesong Wang has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Guangrui Huang
School of Life Sciences, Beijing University of Chinese Medicine, China
3 shared publications - Kai Yuan
School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China
3 shared publications Aimin Yan
2 shared publicationsCongmin Xia
2 shared publicationsHeng Xu
Beijing University of Chinese Medicine School of Life Sciences Beijing
2 shared publicationsHuaijuan Huang
2 shared publications
Latest Publications
- Open Access
- 30 June 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 28 (10) , 2417-2434
The clinical and molecular landscape of thalamic glioma
Background: Thalamic gliomas (TGs) remain a formidable clinical challenge for accurate diagnosis and effective therapy. This study aims to refine molecular diagnosis and surgical management of TGs by integrating clinicopathological and multi-omics data. Methods: We analyzed 106 TGs, comprising 65 diffuse midline glioma (DMG) and 41 non-DMG, using genomic profiling, single-cell RNA sequencing, and orthogonal assays. Surgical outcomes were evaluated using rigorous causal inference frameworks, including propensity score matching and difference-in-differences analyses. Results: Genomic profiling revealed striking mutual exclusivity between H3F3A mutations and CDKN2A/B (9p21) loss. Single-cell and orthogonal assays validated that 9p21 loss emerged as a highly specific adjunctive marker favoring non-DMG over DMG. Causal inference analyses consistently demonstrated that microsurgical third ventriculostomy (mTV) confers profound protection against postoperative hydrocephalus (risk reduction > 60%). Multivariate analysis identified the transfrontal approach as an independent predictor of postoperative motor deficits. Survival analysis showed that the median overall survival of this cohort following surgical resection was 21.0 months. Extent of resection and tumor mutational burden emerged as the principal independent determinants of prognosis, whereas postoperative KPS showed survival stratification in univariable/subgroup analyses but was not independently significant in multivariable model. Conclusions: In this 106-patient cohort study, we delineated the somatic mutational landscape of thalamic glioma and showed that 9p21 loss is mutually exclusive with H3F3A mutations, providing a highly specific adjunctive marker for thalamic glioma. We further demonstrated that maximal surgical resection confers a survival benefit and intraoperative mTV serves as a standardized treatment workflow to optimize care for thalamic glioma.
- 30 June 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 28 (10) , 2417-2434
Open AccessThe clinical and molecular landscape of thalamic glioma
Background: Thalamic gliomas (TGs) remain a formidable clinical challenge for accurate diagnosis and effective therapy. This study aims to refine molecular diagnosis and surgical management of TGs by integrating clinicopathological and multi-omics data. Methods: We analyzed 106 TGs, comprising 65 diffuse midline glioma (DMG) and 41 non-DMG, using genomic profiling, single-cell RNA sequencing, and orthogonal assays. Surgical outcomes were evaluated using rigorous causal inference frameworks, including propensity score matching and difference-in-differences analyses. Results: Genomic profiling revealed striking mutual exclusivity between H3F3A mutations and CDKN2A/B (9p21) loss. Single-cell and orthogonal assays validated that 9p21 loss emerged as a highly specific adjunctive marker favoring non-DMG over DMG. Causal inference analyses consistently demonstrated that microsurgical third ventriculostomy (mTV) confers profound protection against postoperative hydrocephalus (risk reduction > 60%). Multivariate analysis identified the transfrontal approach as an independent predictor of postoperative motor deficits. Survival analysis showed that the median overall survival of this cohort following surgical resection was 21.0 months. Extent of resection and tumor mutational burden emerged as the principal independent determinants of prognosis, whereas postoperative KPS showed survival stratification in univariable/subgroup analyses but was not independently significant in multivariable model. Conclusions: In this 106-patient cohort study, we delineated the somatic mutational landscape of thalamic glioma and showed that 9p21 loss is mutually exclusive with H3F3A mutations, providing a highly specific adjunctive marker for thalamic glioma. We further demonstrated that maximal surgical resection confers a survival benefit and intraoperative mTV serves as a standardized treatment workflow to optimize care for thalamic glioma.
- Open Access
- 3 December 2025
- Published by Elsevier in Materials Today Bio
- Vol. 35
Monometal-doped nanozymes ameliorate rheumatoid arthritis by regulating neutrophil ferroptosis via the MDM2–P53–SLC7A11 pathway
- 3 December 2025
- Published by Elsevier in Materials Today Bio
- Vol. 35
Open AccessMonometal-doped nanozymes ameliorate rheumatoid arthritis by regulating neutrophil ferroptosis via the MDM2–P53–SLC7A11 pathway
- 24 July 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (27) , e02053
Polypeptide Single‐Chain Nanoparticle Derived Artificial Enzyme
Polyamino acids synthesized via ring‐opening polymerization (ROP) of N‐carboxyanhydride (NCA) monomers offer a scalable route to functional polypeptides, but the lack of sequence specificity limits their ability to fold and function like natural enzymes. Here, a series of artificial enzymes is developed based on single‐chain nanoparticles (SCNPs) formed through intramolecular folding of a triblock copolypeptide, polyethylene glycol‐b‐poly(L‐glutamic acid)‐b‐poly(oligo(ethylene glycol)‐L‐glutamate) (PEG113‐b‐PGlu112‐b‐P(Glu‐EG2)99). The central poly‐Glu block is intramolecularly cross‐linked via coordination with transition metal ions (Fe2+/Fe3+, Mn2+, Co2+, Cu2+/Zn2+), mimicking the natural folding of polypeptides into proteins. Co‐precipitation with ammonia water generates metal/alloy oxide nanoclusters within the cross‐linked polyGlu domain, providing a large surface‐to‐volume ratio. The metal oxide nanoclusters function as coenzymes. They not only facilitate a structural transition from α‐helices to β‐strands within the cross‐linked polyGlu domain but also demonstrate specific peroxidase (POD) or superoxide dismutase (SOD) activities, which are tailored to the specific metal species involved. The FeOx‐complexed artificial enzyme (Fe‐enzyme) is selected to exemplify its therapeutic effects of mitigating oxidative stress and inflammation in a rheumatoid arthritis mouse model. These artificial enzymes feature a soft, degradable polypeptide skeleton, tunable side‐chain functionalities, high enzyme‐like activity with minimal metal content (< 5 wt.%), and secondary structures similar to natural proteins.
- 24 July 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (27) , e02053
Polypeptide Single‐Chain Nanoparticle Derived Artificial Enzyme
Polyamino acids synthesized via ring‐opening polymerization (ROP) of N‐carboxyanhydride (NCA) monomers offer a scalable route to functional polypeptides, but the lack of sequence specificity limits their ability to fold and function like natural enzymes. Here, a series of artificial enzymes is developed based on single‐chain nanoparticles (SCNPs) formed through intramolecular folding of a triblock copolypeptide, polyethylene glycol‐b‐poly(L‐glutamic acid)‐b‐poly(oligo(ethylene glycol)‐L‐glutamate) (PEG113‐b‐PGlu112‐b‐P(Glu‐EG2)99). The central poly‐Glu block is intramolecularly cross‐linked via coordination with transition metal ions (Fe2+/Fe3+, Mn2+, Co2+, Cu2+/Zn2+), mimicking the natural folding of polypeptides into proteins. Co‐precipitation with ammonia water generates metal/alloy oxide nanoclusters within the cross‐linked polyGlu domain, providing a large surface‐to‐volume ratio. The metal oxide nanoclusters function as coenzymes. They not only facilitate a structural transition from α‐helices to β‐strands within the cross‐linked polyGlu domain but also demonstrate specific peroxidase (POD) or superoxide dismutase (SOD) activities, which are tailored to the specific metal species involved. The FeOx‐complexed artificial enzyme (Fe‐enzyme) is selected to exemplify its therapeutic effects of mitigating oxidative stress and inflammation in a rheumatoid arthritis mouse model. These artificial enzymes feature a soft, degradable polypeptide skeleton, tunable side‐chain functionalities, high enzyme‐like activity with minimal metal content (< 5 wt.%), and secondary structures similar to natural proteins.
- 20 May 2025
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 11 (6) , 3666-3681
Fe-Doped Carbon Dots Alleviated Rheumatoid Arthritis by Inhibiting Neutrophil NETosis and Autophagy
Rheumatoid arthritis (RA) is an autoimmune disorder primarily affecting joints, characterized by high incidence rates and significantly impairing patients' quality of life. Neutrophils play a pivotal role in RA pathogenesis, making therapeutic interventions targeting neutrophil-mediated inflammatory cascades a promising strategy for RA treatment. Inspired by traditional Tibetan medicinal formulations, which typically combine metallic minerals and organic components, this study developed iron-doped carbon dots (MM-CDs) via a facile one-pot synthesis approach using magnetite (Cishi) and medicated leaven (Shenqu). The therapeutic efficacy of MM-CDs was subsequently evaluated in a mouse model of RA. The results indicated that MM-CDs effectively alleviated RA by disrupting neutrophil-induced inflammatory cascades. Specifically, MM-CDs inhibited NETosis, significantly downregulated myeloperoxidase (MPO), citrullinated histone H3 (Cit-H3), and peptidyl arginine deiminase 4 (PAD-4) in joint tissues (P < 0.05). Furthermore, MM-CDs modulated autophagy pathways, suppressing LC3B and Beclin-1 expression, thereby reducing neutrophil survival. Additionally, MM-CDs promoted apoptosis in neutrophils, evidenced by increased cleaved caspase-3/PARP expression and decreased Bcl-2 levels in LPS-stimulated neutrophils. This study demonstrates that MM-CDs represent a novel and effective therapeutic strategy for RA. Importantly, the treatment exhibited no liver or kidney toxicity in the RA mouse model, highlighting its potential for safe clinical translation.
- 20 May 2025
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 11 (6) , 3666-3681
Fe-Doped Carbon Dots Alleviated Rheumatoid Arthritis by Inhibiting Neutrophil NETosis and Autophagy
Rheumatoid arthritis (RA) is an autoimmune disorder primarily affecting joints, characterized by high incidence rates and significantly impairing patients' quality of life. Neutrophils play a pivotal role in RA pathogenesis, making therapeutic interventions targeting neutrophil-mediated inflammatory cascades a promising strategy for RA treatment. Inspired by traditional Tibetan medicinal formulations, which typically combine metallic minerals and organic components, this study developed iron-doped carbon dots (MM-CDs) via a facile one-pot synthesis approach using magnetite (Cishi) and medicated leaven (Shenqu). The therapeutic efficacy of MM-CDs was subsequently evaluated in a mouse model of RA. The results indicated that MM-CDs effectively alleviated RA by disrupting neutrophil-induced inflammatory cascades. Specifically, MM-CDs inhibited NETosis, significantly downregulated myeloperoxidase (MPO), citrullinated histone H3 (Cit-H3), and peptidyl arginine deiminase 4 (PAD-4) in joint tissues (P < 0.05). Furthermore, MM-CDs modulated autophagy pathways, suppressing LC3B and Beclin-1 expression, thereby reducing neutrophil survival. Additionally, MM-CDs promoted apoptosis in neutrophils, evidenced by increased cleaved caspase-3/PARP expression and decreased Bcl-2 levels in LPS-stimulated neutrophils. This study demonstrates that MM-CDs represent a novel and effective therapeutic strategy for RA. Importantly, the treatment exhibited no liver or kidney toxicity in the RA mouse model, highlighting its potential for safe clinical translation.
- Open Access
- 12 May 2022
- Published by Wiley in Disease Markers
- Vol. 2022, 1-10
The Association between Serum Anion Gap and All-Cause Mortality in Cerebral Infarction Patients after Treatment with rtPA: A Retrospective Analysis
Background. No epidemiological study has determined the association between the anion gap (AG) and all-cause mortality in cerebral infarction patients after treatment with rtPA. This study is aimed at using AG levels as a prognostic factor for evaluating cerebral infarction patients after receiving rtPA treatment and to help the resident physicians accurately evaluate the therapeutic plan of rtPA. Methods. We extracted clinical data from the public database (MIMIC-IV database V1.0) and used the Kaplan-Meier curve to estimate the survival probabilities of cerebral infarction patients after rtPA treatment for the one-year, four-year, and whole period by log-rank test in 948 intensive care unit patients. Cox proportional hazard models were used to assess the association between AG and one-year, four-year, and whole period mortality in cerebral infarction patients after treatment with rtPA. Results. Kaplan-Meier survival curve indicated a higher AG value is significantly associated with an increased risk of one-year, four-year, and whole-period all-cause mortality in cerebral infarction patients after treatment with rtPA. Model I adjusted for ethnicity, age, gender, and skin tone. Model II adjusted for ethnicity, age, gender, skin tone, hypertension, diabetes, coronary atherosclerosis, congestive heart failure, peripheral vascular, hyperlipidemia, acute myocardial infarction (AMI), respiratory failure, and end-stage renal diseaseesrd (ESRD). On the basis of model II, model III adjusted for WBC, BUN, creatinine, platelet, MCH, MCHC, MCV, RBC, and RDW. In addition, there was better predictive ability between higher AG levels and mortality in certain subgroups, such as patients with , . Conclusion. Serum AG is positively related to all-cause mortality in cerebral infarction patients after treatment with rtPA.
- 12 May 2022
- Published by Wiley in Disease Markers
- Vol. 2022, 1-10
Open AccessThe Association between Serum Anion Gap and All-Cause Mortality in Cerebral Infarction Patients after Treatment with rtPA: A Retrospective Analysis
Background. No epidemiological study has determined the association between the anion gap (AG) and all-cause mortality in cerebral infarction patients after treatment with rtPA. This study is aimed at using AG levels as a prognostic factor for evaluating cerebral infarction patients after receiving rtPA treatment and to help the resident physicians accurately evaluate the therapeutic plan of rtPA. Methods. We extracted clinical data from the public database (MIMIC-IV database V1.0) and used the Kaplan-Meier curve to estimate the survival probabilities of cerebral infarction patients after rtPA treatment for the one-year, four-year, and whole period by log-rank test in 948 intensive care unit patients. Cox proportional hazard models were used to assess the association between AG and one-year, four-year, and whole period mortality in cerebral infarction patients after treatment with rtPA. Results. Kaplan-Meier survival curve indicated a higher AG value is significantly associated with an increased risk of one-year, four-year, and whole-period all-cause mortality in cerebral infarction patients after treatment with rtPA. Model I adjusted for ethnicity, age, gender, and skin tone. Model II adjusted for ethnicity, age, gender, skin tone, hypertension, diabetes, coronary atherosclerosis, congestive heart failure, peripheral vascular, hyperlipidemia, acute myocardial infarction (AMI), respiratory failure, and end-stage renal diseaseesrd (ESRD). On the basis of model II, model III adjusted for WBC, BUN, creatinine, platelet, MCH, MCHC, MCV, RBC, and RDW. In addition, there was better predictive ability between higher AG levels and mortality in certain subgroups, such as patients with , . Conclusion. Serum AG is positively related to all-cause mortality in cerebral infarction patients after treatment with rtPA.
- Open Access
- 1 January 2020
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2020 (1) , 8850259
The Mechanisms of Sijunzi Decoction in the Treatment of Chronic Gastritis Revealed by Network Pharmacology
Chronic gastritis is characterized by inflammation in the gastric mucosa with a vicious circle in inflammatory cells and inflammatory mediators. Stomach adenocarcinoma would occur in the metaplastic gastric mucosa of chronic gastritis. Sijunzi decoction is a famous classical formula for the treatment of chronic gastritis. Although previous studies revealed some functions of Sijunzi decoction in treating chronic gastritis, the underlying mechanisms have not been illustrated clearly. In this study, we used network pharmacology to investigate the mechanism of Sijunzi decoction in treating chronic gastritis. Firstly, online datasets TCMSP, SWISS, and DisGeNET were used to investigate the functional mechanism of Sijunzi decoction against chronic gastritis and 18 genes were identified as targets of Sijunzi decoction in chronic gastritis. These 18 genes can be categorized into immunologically related genes and cancer‐related genes. GO analysis showed that the 18 target genes were mainly enriched in angiogenesis, nitric oxide biosynthetic process, ERK1 and ERK2 cascade, cellular response to drug, and MAPK cascade. So, Sijunzi decoction alleviated chronic gastritis by inhibiting the local inflammatory response. Furthermore, we also investigated the impact of Sijunzi decoction on the peripheral blood leukocytes with our own RNA sequencing (RNA‐seq) data of 11 chronic superficial gastritis patients. 102 differentially expressed genes (DEGs) were identified by comparing RNA‐seq data of chronic superficial gastritis patients with healthy control groups. After performing a functional analysis on 102 DEGs and Sijunzi decoction potential targets and taking the intersection of these pathways, we found that platelet activation, angiogenesis, and pathways in cancer were candidate target pathways regulated by Sijunzi decoction. Thus, Sijunzi decoction also alleviates chronic gastritis by suppressing inflammatory response of peripheral blood leukocytes. Our results showed that Sijunzi decoction can ameliorate the local gastric inflammation and inflammations in peripheral blood leukocytes and might also reduce the incidence of stomach cancer in chronic gastritis.
- 1 January 2020
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2020 (1) , 8850259
Open AccessThe Mechanisms of Sijunzi Decoction in the Treatment of Chronic Gastritis Revealed by Network Pharmacology
Chronic gastritis is characterized by inflammation in the gastric mucosa with a vicious circle in inflammatory cells and inflammatory mediators. Stomach adenocarcinoma would occur in the metaplastic gastric mucosa of chronic gastritis. Sijunzi decoction is a famous classical formula for the treatment of chronic gastritis. Although previous studies revealed some functions of Sijunzi decoction in treating chronic gastritis, the underlying mechanisms have not been illustrated clearly. In this study, we used network pharmacology to investigate the mechanism of Sijunzi decoction in treating chronic gastritis. Firstly, online datasets TCMSP, SWISS, and DisGeNET were used to investigate the functional mechanism of Sijunzi decoction against chronic gastritis and 18 genes were identified as targets of Sijunzi decoction in chronic gastritis. These 18 genes can be categorized into immunologically related genes and cancer‐related genes. GO analysis showed that the 18 target genes were mainly enriched in angiogenesis, nitric oxide biosynthetic process, ERK1 and ERK2 cascade, cellular response to drug, and MAPK cascade. So, Sijunzi decoction alleviated chronic gastritis by inhibiting the local inflammatory response. Furthermore, we also investigated the impact of Sijunzi decoction on the peripheral blood leukocytes with our own RNA sequencing (RNA‐seq) data of 11 chronic superficial gastritis patients. 102 differentially expressed genes (DEGs) were identified by comparing RNA‐seq data of chronic superficial gastritis patients with healthy control groups. After performing a functional analysis on 102 DEGs and Sijunzi decoction potential targets and taking the intersection of these pathways, we found that platelet activation, angiogenesis, and pathways in cancer were candidate target pathways regulated by Sijunzi decoction. Thus, Sijunzi decoction also alleviates chronic gastritis by suppressing inflammatory response of peripheral blood leukocytes. Our results showed that Sijunzi decoction can ameliorate the local gastric inflammation and inflammations in peripheral blood leukocytes and might also reduce the incidence of stomach cancer in chronic gastritis.